{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:03:45Z","timestamp":1745298225794,"version":"3.37.3"},"reference-count":43,"publisher":"Portland Press Ltd.","issue":"18","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:p>Destabilization of human transthyretin leads to its aggregation into amyloid fibrils, which causes a rare, progressive and fatal systemic disorder called ATTR amyloidosis. By contrast, murine transthyretin is known to be very stable and therefore does not aggregate into amyloid fibrils in vivo or in vitro. We examined the hydrophobic residues responsible for the high-stability and low-aggregation properties of murine transthyretin using site-directed mutagenesis. Urea-induced unfolding and thioflavin T fluorescence aggregation assay revealed that Leu73 of murine transthyretin largely contributes to its high stability and low aggregation properties: the I73L mutation stabilized human transthyretin, while the L73I mutation destabilized murine transthyretin. In addition, the I26V\/I73L mutation stabilized the amyloidogenic V30M mutant of human transthyretin to the same degree as the suppressor mutation T119M, which protects transthyretin against amyloid fibril aggregation. The I73L mutation resulted in no significant differences in the overall structure of the transthyretin tetramer or the contacts of side-chains in the hydrophobic core of the monomer. We also found that Leu73 of murine transthyretin is conserved in many mammals, while Ile73 of human transthyretin is conserved in monkeys and cats. These studies will provide new insights into the stability and aggregation properties of transthyretin from various mammals.<\/jats:p>","DOI":"10.1042\/bcj20220203","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T11:48:46Z","timestamp":1663069726000},"page":"1999-2011","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The hydrophobic residue Leu73 is crucial for the high stability and low aggregation properties of murine transthyretin"],"prefix":"10.1042","volume":"479","author":[{"given":"Mei","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Obita","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0450-0339","authenticated-orcid":false,"given":"Mineyuki","family":"Mizuguchi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"2022093010304702100_BCJ-2022-0203C1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: recommendations by the international society of amyloidosis (ISA) nomenclature committee","volume":"25","year":"2018","journal-title":"Amyloid"},{"key":"2022093010304702100_BCJ-2022-0203C2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1210\/endo-63-2-256","article-title":"Pre-albumin: a thyroxinebinding protein of human plasma","volume":"63","year":"1958","journal-title":"Endocrinology"},{"key":"2022093010304702100_BCJ-2022-0203C3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1172\/JCI104701","article-title":"Observations concerning the binding of thyroid hormones by human serum prealbumin","volume":"42","year":"1963","journal-title":"J. Clin. Invest."},{"key":"2022093010304702100_BCJ-2022-0203C4","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1172\/JCI105889","article-title":"Retinol-binding protein: the transport protein for vitamin A in human plasma","volume":"47","year":"1968","journal-title":"J. Clin. Invest."},{"key":"2022093010304702100_BCJ-2022-0203C5","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1021\/bi00151a036","article-title":"Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro","volume":"31","year":"1992","journal-title":"Biochemistry"},{"key":"2022093010304702100_BCJ-2022-0203C6","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","year":"1996","journal-title":"Biochemistry"},{"key":"2022093010304702100_BCJ-2022-0203C7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1021\/ar020073i","article-title":"Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin\u202famyloidoses","volume":"38","year":"2005","journal-title":"Acc. Chem. Res."},{"key":"2022093010304702100_BCJ-2022-0203C8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin\u202famyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","year":"2012","journal-title":"\u202fJ. Mol. Biol."},{"key":"2022093010304702100_BCJ-2022-0203C9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: a multifaceted protein","volume":"5","year":"2014","journal-title":"Biomol.\u202fConcepts"},{"key":"2022093010304702100_BCJ-2022-0203C10","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"2022093010304702100_BCJ-2022-0203C11","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","year":"1990","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2022093010304702100_BCJ-2022-0203C12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cardfail.2016.10.008","article-title":"Transthyretin cardiac amyloidosis in older Americans","volume":"22","year":"2016","journal-title":"J. Card. Fail."},{"key":"2022093010304702100_BCJ-2022-0203C13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00415-017-8640-7","article-title":"Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan","volume":"265","year":"2018","journal-title":"J. Neurol."},{"key":"2022093010304702100_BCJ-2022-0203C14","doi-asserted-by":"publisher","first-page":"12119","DOI":"10.1021\/bi00096a024","article-title":"Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity","volume":"32","year":"1993","journal-title":"Biochemistry"},{"key":"2022093010304702100_BCJ-2022-0203C15","doi-asserted-by":"publisher","first-page":"13560","DOI":"10.1021\/bi991021c","article-title":"The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions","volume":"38","year":"1999","journal-title":"Biochemistry"},{"key":"2022093010304702100_BCJ-2022-0203C16","doi-asserted-by":"publisher","first-page":"14943","DOI":"10.1073\/pnas.261419998","article-title":"The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis","volume":"98","year":"2001","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2022093010304702100_BCJ-2022-0203C17","doi-asserted-by":"publisher","first-page":"15053","DOI":"10.1021\/bi0353528","article-title":"Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy","volume":"42","year":"2003","journal-title":"Biochemistry"},{"key":"2022093010304702100_BCJ-2022-0203C18","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1021\/bi048838c","article-title":"Dimeric transthyretin variant assembles into spherical neurotoxins","volume":"44","year":"2005","journal-title":"Biochemistry"},{"key":"2022093010304702100_BCJ-2022-0203C19","doi-asserted-by":"publisher","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization","volume":"93","year":"1996","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2022093010304702100_BCJ-2022-0203C20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","year":"2003","journal-title":"Science"},{"key":"2022093010304702100_BCJ-2022-0203C21","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","year":"2012","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2022093010304702100_BCJ-2022-0203C22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"2022093010304702100_BCJ-2022-0203C23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2047-9158-3-19","article-title":"Recent advances in transthyretin amyloidosis therapy","volume":"3","year":"2014","journal-title":"Transl. Neurodegener."},{"key":"2022093010304702100_BCJ-2022-0203C24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/gcen.2000.7520","article-title":"Evolution of the thyroid hormone-binding protein, transthyretin","volume":"119","year":"2000","journal-title":"Gen. Comp. Endocrinol."},{"key":"2022093010304702100_BCJ-2022-0203C25","doi-asserted-by":"publisher","first-page":"113735","DOI":"10.1016\/j.ygcen.2021.113735","article-title":"Evolution of thyroid hormone distributor proteins in fish","volume":"305","year":"2021","journal-title":"Gen. Comp. Endocrinol."},{"key":"2022093010304702100_BCJ-2022-0203C26","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1074\/jbc.M708028200","article-title":"Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins","volume":"283","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2022093010304702100_BCJ-2022-0203C27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0022-2836(76)90091-7","article-title":"Three-state denaturation of alpha-lactalbumin by guanidine hydrochloride","volume":"106","year":"1976","journal-title":"J. Mol. Biol."},{"key":"2022093010304702100_BCJ-2022-0203C28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1","volume":"177","year":"1989","journal-title":"Anal. Biochem."},{"key":"2022093010304702100_BCJ-2022-0203C29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-019-08609-z","article-title":"A molecular mechanism for transthyretin amyloidogenesis","volume":"10","year":"2019","journal-title":"Nat. Commun."},{"key":"2022093010304702100_BCJ-2022-0203C30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","year":"2014","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2022093010304702100_BCJ-2022-0203C31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1098-1004(1998)12:2&lt;135::AID-HUMU9&gt;3.0.CO;2-K","article-title":"Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy in a Bangladeshi family. Mutations in brief no. 158. Online","volume":"12","year":"1998","journal-title":"Hum. Mutat."},{"key":"2022093010304702100_BCJ-2022-0203C32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1006\/jmbi.2000.4415","article-title":"Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution","volume":"306","year":"2001","journal-title":"J. Mol. Biol."},{"key":"2022093010304702100_BCJ-2022-0203C33","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro","volume":"161","year":"2002","journal-title":"Am. J. Pathol."},{"key":"2022093010304702100_BCJ-2022-0203C34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/13506120701464396","article-title":"In vivo stabilization of mutant human transthyretin in transgenic mice","volume":"14","year":"2007","journal-title":"Amyloid"},{"key":"2022093010304702100_BCJ-2022-0203C35","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/ncomms4822","article-title":"Mutations in the PQBP1 gene prevent its interaction with the spliceosomal protein U5-15 kD","volume":"5","year":"2014","journal-title":"Nat. Commun."},{"key":"2022093010304702100_BCJ-2022-0203C36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2022093010304702100_BCJ-2022-0203C37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2022093010304702100_BCJ-2022-0203C38","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1021\/jm401832j","article-title":"Crystal structures of human transthyretin complexed with glabridin","volume":"57","year":"2014","journal-title":"J. Med. Chem."},{"key":"2022093010304702100_BCJ-2022-0203C39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"2022093010304702100_BCJ-2022-0203C40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2022093010304702100_BCJ-2022-0203C41","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2022093010304702100_BCJ-2022-0203C42","unstructured":"Schrodinger, LLC. (2010) The PyMOL Molecular Graphics System, Version 1.3r1"},{"key":"2022093010304702100_BCJ-2022-0203C43","doi-asserted-by":"publisher","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/479\/18\/1999\/937906\/bcj-2022-0203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/479\/18\/1999\/937906\/bcj-2022-0203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T10:31:31Z","timestamp":1664533891000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/479\/18\/1999\/231790\/The-hydrophobic-residue-Leu73-is-crucial-for-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":43,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bcj20220203","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"type":"print","value":"0264-6021"},{"type":"electronic","value":"1470-8728"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}